Versant Venture Capital V, L.P. Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Versant Venture Capital V, L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Versant Venture Capital V, L.P.. Versant Venture Capital V, L.P. is 10% Owner in Crinetics Pharmaceuticals, Inc. ($CRNX) and 10% Owner in CRISPR Therapeutics AG ($CRSP) and 10% Owner in Gritstone Oncology, Inc. ($GRTS).
Latest Insider Trading Transactions of Versant Venture Capital V, L.P.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CRNX, CRSP, GRTS
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 06 2019 | CRNX | Crinetics Pharmace ... | Versant Venture Capital V, L.P ... | 10% Owner | Sell | J | 0.00 | 678 | 0 | 0 | 678 to 0 (-100.00 %) |
| Feb 06 2019 | CRNX | Crinetics Pharmace ... | Versant Venture Capital V, L.P ... | 10% Owner | Buy | J | 0.00 | 678 | 0 | 678 | 0 to 678 |
| Feb 06 2019 | CRNX | Crinetics Pharmace ... | Versant Venture Capital V, L.P ... | 10% Owner | Sell | J | 0.00 | 9,473 | 0 | 0 | 9.5 K to 0 (-100.00 %) |
| Feb 06 2019 | CRNX | Crinetics Pharmace ... | Versant Venture Capital V, L.P ... | 10% Owner | Buy | J | 0.00 | 9,473 | 0 | 9,473 | 0 to 9.5 K |
| Feb 06 2019 | CRNX | Crinetics Pharmace ... | Versant Venture Capital V, L.P ... | 10% Owner | Sell | J | 0.00 | 33,903 | 0 | 192,122 | 226 K to 192.1 K (-15.00 %) |
| Feb 06 2019 | CRNX | Crinetics Pharmace ... | Versant Venture Capital V, L.P ... | 10% Owner | Sell | J | 0.00 | 14,828 | 0 | 84,161 | 99 K to 84.2 K (-14.98 %) |
| Feb 06 2019 | CRNX | Crinetics Pharmace ... | Versant Venture Capital V, L.P ... | 10% Owner | Sell | J | 0.00 | 13,387 | 0 | 75,949 | 89.3 K to 75.9 K (-14.99 %) |
| Feb 06 2019 | CRNX | Crinetics Pharmace ... | Versant Venture Capital V, L.P ... | 10% Owner | Sell | J | 0.00 | 445,470 | 0 | 2,524,456 | 3 M to 2.5 M (-15.00 %) |
| Oct 02 2018 | GRTS | Gritstone Oncology ... | Versant Venture Capital V, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 929,020 | 0 | 0 | |
| Oct 02 2018 | GRTS | Gritstone Oncology ... | Versant Venture Capital V, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 2,173,909 | 0 | 0 | |
| Oct 02 2018 | GRTS | Gritstone Oncology ... | Versant Venture Capital V, L.P ... | 10% Owner | Buy | C | 0.00 | 3,102,929 | 0 | 3,102,929 | 0 to 3.1 M |
| Jul 20 2018 | CRNX | Crinetics Pharmace ... | Versant Venture Capital V, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 103,293 | 0 | 0 | |
| Jul 20 2018 | CRNX | Crinetics Pharmace ... | Versant Venture Capital V, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 45,192 | 0 | 0 | |
| Jul 20 2018 | CRNX | Crinetics Pharmace ... | Versant Venture Capital V, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 40,826 | 0 | 0 | |
| Jul 20 2018 | CRNX | Crinetics Pharmace ... | Versant Venture Capital V, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 1,357,240 | 0 | 0 | |
| Jul 20 2018 | CRNX | Crinetics Pharmace ... | Versant Venture Capital V, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 640,332 | 0 | 0 | |
| Jul 20 2018 | CRNX | Crinetics Pharmace ... | Versant Venture Capital V, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 280,485 | 0 | 0 | |
| Jul 20 2018 | CRNX | Crinetics Pharmace ... | Versant Venture Capital V, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 253,091 | 0 | 0 | |
| Jul 20 2018 | CRNX | Crinetics Pharmace ... | Versant Venture Capital V, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 8,413,817 | 0 | 0 | |
| Jul 20 2018 | CRNX | Crinetics Pharmace ... | Versant Venture Capital V, L.P ... | 10% Owner | Buy | C | 0.00 | 31,396 | 0 | 226,025 | 194.6 K to 226 K (+16.13 %) |
| Jul 20 2018 | CRNX | Crinetics Pharmace ... | Versant Venture Capital V, L.P ... | 10% Owner | Buy | C | 0.00 | 13,736 | 0 | 98,989 | 85.3 K to 99 K (+16.11 %) |
| Jul 20 2018 | CRNX | Crinetics Pharmace ... | Versant Venture Capital V, L.P ... | 10% Owner | Buy | C | 0.00 | 12,409 | 0 | 89,336 | 76.9 K to 89.3 K (+16.13 %) |
| Jul 20 2018 | CRNX | Crinetics Pharmace ... | Versant Venture Capital V, L.P ... | 10% Owner | Buy | C | 0.00 | 412,534 | 0 | 2,969,926 | 2.6 M to 3 M (+16.13 %) |
| Jul 20 2018 | CRNX | Crinetics Pharmace ... | Versant Venture Capital V, L.P ... | 10% Owner | Buy | C | 0.00 | 194,629 | 0 | 194,629 | 0 to 194.6 K |
| Jul 20 2018 | CRNX | Crinetics Pharmace ... | Versant Venture Capital V, L.P ... | 10% Owner | Buy | C | 0.00 | 85,253 | 0 | 85,253 | 0 to 85.3 K |
| Jul 20 2018 | CRNX | Crinetics Pharmace ... | Versant Venture Capital V, L.P ... | 10% Owner | Buy | C | 0.00 | 76,927 | 0 | 76,927 | 0 to 76.9 K |
| Jul 20 2018 | CRNX | Crinetics Pharmace ... | Versant Venture Capital V, L.P ... | 10% Owner | Buy | C | 0.00 | 2,557,392 | 0 | 2,557,392 | 0 to 2.6 M |
| Apr 26 2018 | CRSP | CRISPR Therapeutic ... | Versant Venture Capital V, L.P ... | 10% Owner | Sell | S | 51.00 | 1,528 | 77,928 | 115,645 | 117.2 K to 115.6 K (-1.30 %) |
| Apr 26 2018 | CRSP | CRISPR Therapeutic ... | Versant Venture Capital V, L.P ... | 10% Owner | Sell | S | 51.00 | 653 | 33,303 | 49,419 | 50.1 K to 49.4 K (-1.30 %) |
| Apr 26 2018 | CRSP | CRISPR Therapeutic ... | Versant Venture Capital V, L.P ... | 10% Owner | Sell | S | 50.60 | 589 | 29,803 | 44,582 | 45.2 K to 44.6 K (-1.30 %) |
| Apr 26 2018 | CRSP | CRISPR Therapeutic ... | Versant Venture Capital V, L.P ... | 10% Owner | Sell | S | 51.00 | 20,071 | 1,023,621 | 1,519,505 | 1.5 M to 1.5 M (-1.30 %) |
Page: 1